Predicting radioiodine therapy response in advanced and recurrent thyroid cancer. [PDF]
Condello V +5 more
europepmc +1 more source
Single 0.9-mg intramuscular rhTSH dose achieves target TSH levels in differentiated thyroid carcinoma. [PDF]
Leite PHF, Pires MC, Penna GC.
europepmc +1 more source
Optimal timing of post-therapeutic [<sup>131</sup>I]NaI whole-body scintigraphy in predominantly low- and intermediate-risk differentiated thyroid cancer: a secondary analysis of prospectively acquired data and a structured literature review. [PDF]
Pfestroff A +13 more
europepmc +1 more source
Auger-Emitting Radionuclides in Radiopharmaceutical Research: Decay-Associated Processes, Vector-Dependent Localization, and Translational Perspectives. [PDF]
Schomäcker K +10 more
europepmc +1 more source
Bilateral highly differentiated follicular carcinoma of ovarian origin with extensive abdominal metastasis: A case report. [PDF]
Wang L, Dong H, Lou C, Fu Q, Qiu Y.
europepmc +1 more source
Early versus delayed oral sialagogues for the prevention of salivary gland dysfunction after radioiodine therapy in differentiated thyroid cancer: a systematic review. [PDF]
Frankowski Dagostin A +3 more
europepmc +1 more source
Status of Nuclear Medicine in Nepal: Current Infrastructure, Challenges, and Future Perspectives. [PDF]
Yadav AK +6 more
europepmc +1 more source
Sex and age at exposure influence <sup>131</sup>I biodistribution and dosimetry in Sprague-Dawley rats. [PDF]
Schroff A +8 more
europepmc +1 more source
Efficacy of redifferentiation therapy in radioactive iodine refractory thyroid cancer: a systematic review and meta-analysis. [PDF]
Zampella E +8 more
europepmc +1 more source
Feasibility simulation study of positronium lifetime imaging with the Biograph Vision Quadra and J-PET tomographs. [PDF]
Parzych S +41 more
europepmc +1 more source

